LORATADINE , FEXOFENADINE , Dupilumab, Matched placebo to test
EFC16973
Phase 3 small_molecule active
Quick answer
LORATADINE , FEXOFENADINE , Dupilumab, Matched placebo to test for Pruritus is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Pruritus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active